In a fashion similar to that observed for autophagosome formation, knock down of Beclin1 or ATG5 reduced the lethality of GZ17-6.02 and abolished the dose-dependent effect on tumor cell killing (Figure 6). The gene discussed is BECN1; the disease is neoplasm.